PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 04/10/2020

Pipeline Type

Dietary Supplements

Phase Of Development

Phase 3

Sponsors and Collaborators

Vitaflo International, Ltd / Nestle

Mechanism of Action

Mechanism Description

medium chain triglyceride- based (MCT) food

Populations Tested In

patients 3-75 yr old w epilepsy who are consuming normal diet but limiting intake of food high in carbohydrate and sugars.

Special FDA Designation

Nonprofit or Government Support

N/A

Nonprofit or Government Support Description

N/A

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

UK: Great Ormond Street Hosp Natl Hosp for Neuro and Neurosurg

Join Our Newsletter

Want to get notified about new devices? Stay up to date with the latest epilepsy news and stories from the community.